|
Submission of Manuscripts
Four copies of manuscripts and illustrations should be submitted to the Editor-in-Chief.
For Fundamental Pharmacology, please send your manuscript to:
Pascal Bousquet
Laboratoire de Neurobiologie et Pharmacologie Cardiovasculaire
Facult¨¦ de M¨¦decine
11 rue Humann
67085 Strasbourg cedex
France
Fax : +33 3 90 24 33 88
E-mail: Denise.Jung@medecine.u-strasbg.fr
For Clinical Pharmacology, please send your manuscript to:
Faiez Zannad
CIC/INSERM/CHU
Hôpital Jeanne d'Arc
54200 Dommartin-Les-Toul
France
Fax: +33 3 83 65 66 19
Email: n.ziegler@chu-nancy.fr
All manuscripts should be accompanied by a clear statement that the work has not been published elsewhere and is not under review with another journal. When there is more than one author, a clear statement should be made in the submission letter that ALL co-authors have agreed to the submission of the final manuscript.
Authors should keep copies of all material submitted. Manuscripts will not be returned and top copies of the artwork will be returned only if this is specifically indicated on the figures.
To help ensure that papers are reviewed by the most suitable referees, authors can provide a list of up to four candidate referees (including names, addresses, fax and email) who are not directly concerned with the research being submitted. The Editors reserve the right to choose different referees from the ones suggested.
Types of Manuscripts Accepted
The Journal publishes new material only. Authors should not submit work that has been published elsewhere, except in abstract form, and where a previous abstract has been published clear reference must be made to it in the Introduction.
The major part of each issue will be devoted to Original articles. These must describe significant and original observations and provide sufficient detail so that the observations can be critically evaluated and, if necessary, repeated. Short communications and Review articles will also be included in the Journal (see below for details).
Organization of the Manuscript
All manuscripts should be typewritten throughout on one side of A4 (approx. 205 ¡Á 295 mm or 8 ¡Á 11 in.) white paper with double spacing (including figure legends and references) and with 3.5 cm (1.3 in.) margins. Pages should be numbered sequentially in the upper right corner, including all typed material in the numbering. One set of figures should be mounted and ready to be sent to the printers. The other copies of the figures can be photocopies (Xerox, etc.) for line drawings but must be photographs for half-tone figures.
Disks
The final accepted manuscript must be provided on disk (accompanied by an Electronic Submission of Manuscript Form) and should contain a single word-processor file with the entire text, followed by tables and figure legends. Authors must ensure that files have been updated to incorporate all revisions, and hence that the version on the disk matches the final hard copy. The disk should be accompanied by a covering letter specifying manuscript number, operating system and software program.
Title page
This must include in the following order: title - a full title and a running title not in excess of 50 letter spaces; authors' names -first names and surnames of each author, name and address (including full postal address, e-mail address, telephone and fax numbers) of the person who will deal with correspondence, including proofs; affiliation - address(es) from which the work originated linked to authors' names by superscript; abstracts and keywords -an abstract (max. 300 words) outlining the study in its entirety and a list of three to six keywords should be included; abbreviations -a list of abbreviations used may be included. Abbreviations should be kept to an absolute minimum. The word must always be written out in full when first used and the proposed abbreviation given in parentheses.
Main text
Original articles should not exceed 5000 words and should contain the following section: Introduction, which outlines the historical or logical origins of the study without repeating the abstract or summarizing the results; Materials and methods; Results in which the observations are presented with minimal reference to earlier literature or to possible interpretations; Discussion may usefully start with a brief summary of the major findings, but repetition of parts of the abstract or of the results section should be avoided; and Conclusion. The sections Acknowledgements, References, Tables, Figures, Figure Legends and Footnotes should follow the main text on separate sheets and in that order. Footnotes should be kept to a minimum. There should be an indication in the main text to show the most appropriate placement of each table and figure.
References
References to articles, chapters, monographs or other publications should be in the Vancouver style, i.e. they should be numbered sequentially (by Arabic numerals in [brackets], e.g. [1]) in the order in which they are first mentioned in the text. In the list of references, references are listed numerically. References cited only in legends should be numbered in accordance with a sequence established by the first identification in the text of the particular table or illustration. The references themselves should be abbreviated according to the style used in Index Medicus or the World List of Scientific Periodicals, 4th edition. Unpublished observations and personal communications should not be listed but may be inserted in the text. Papers which have been accepted for publication should be included in the list of references as 'in press'. Authors are responsible for verifying the wording of all references and that references of unpublished work are approved by the original author.
In the list of references, journal articles should be listed as follows:
1 Puybasset L., Giudicellli J.F., Berdeaux A. Coronary effects of exogenous and endogenous bradykinin in conscious dogs. Fundam. Clin. Pharmacol. (1997) 11, 322-330
Books should be listed as:
2 Brown H. & Kozlowski R. Physiology and Pharmacology of the Heart. Blackwell Science Ltd, Oxford, UK. 1997.
or:
3 Marshall J., Pharmacologic Treatment of Gastrointestinal Malignancies, in: Lewis J.H. & DuBois A. (Eds.), Current Clinical Topics in Gastrointestinal Pharmacology, Blackwell Science Inc., Boston, USA. 1997, pp 224-241
Illustrations
There is no limit set on the number of illustrations, but authors should use them sparingly, making sure that each figure is relevant to the text and that the figures are presented in the order in which they are mentioned in the text. Line drawings and photographs should be consecutively numbered with Arabic numerals (1, 2, etc.). Tables should be consecutively numbered with Roman numerals (I, II, etc.). Each figure and table submitted should be clearly labelled with the name of the author(s), the title of the paper and the figure or table number. Wherever possible illustrations should be submitted in their desired final size, to fit the width of a single column of text, i.e. 88 mm wide, or where it is necessary they should be 184 mm in maximum width. The final size of the printed figure cannot exceed 230 ¡Á 184 mm including legends, and where a reduction is required this should be indicated on the figures. Figure and table legends should explain each figure and table as fully as possible, referring the reader to the text only on rare occasions in order to avoid repeating in the legends material that must be included in the text.
Electronic artwork. The journal welcomes submission of artwork electronically. Please refer to our electronic media pages for more information.
Colour
It is the policy of Fundamental and Clinical Pharmacology for authors to pay the full cost for the reproduction of their colour artwork. Therefore, please note that if there is colour artwork in your manuscript when it is accepted for publication, Blackwell Publishing require you to complete and return a colourwork agreement form before your paper can be published. This form can be downloaded as a PDF* from the internet. The web address for the form is: http://www.blackwellpublishing.com/pdf/Sub3000_X_CoW.pdf
If you are unable to access the internet, or are unable to download the form, please contact Denise Jung at the following address and she will be able to email or fax a form to you:
Laboratoire de Neurobiologie et Pharmacologie Cardiovasculaire
Facult¨¦ de M¨¦decine de Strasbourg
Universit¨¦ Louis Pateur
11 Rue Humann
67085 Strasbourg cedex
France
Tel: +33 3 88 35 87 49
Fax: +33 3 88 24 14 72
Email: Denise.Jung@medecine.u-strasbg.fr
Once completed, please return the form to the Production Editor at:
Production Editor for FCP
Blackwell Publishing
9600 Garsington Road
Oxford OX4 2DQ, UK
Tel: +44 (0)1865 476472
Fax: +44(0)1865 471472
Email: fcp@oxon.blackwellpublishing.com
Any article received by Blackwell Publishing with colour work will not be published until the form has been returned.
* To read PDF files, you must have Acrobat Reader installed on your computer. If you do not have this program, this is available as a free download from the following web address: http://www.adobe.com/products/acrobat/readstep2.html
Short communications
Short communications that describe highly original findings and that justify rapid publication will also be considered for publication in the Journal. Short communications should be limited to 1000 words including references, or the equivalent space if tables and figures, which should be kept to a minimum, are included. Each short communication should be preceded by a succinct summary. Manuscripts need not be divided into sections as for full length papers but can be so divided at the author's discretion. Editorial and publishing procedures will be expedited to assure rapid publication. In general, papers will be either accepted or rejected. Papers that require significant modification in response to referees' comments will be rejected.
Review Articles
Review articles are commentaries of on topics of particular interest, which are processed with minimal publication delay. Review articles will be peer-reviewed.
Experimental Subjects
When human subjects are used, manuscripts must be accompanied by a statement that the experiments were undertaken with the understanding and written consent of each subject. Authors should be aware of the Code of Ethics of the World Medical Association (Declaration of Helsinki), which has been printed in the British Medical Journal (18 July 1964).
When experimental animals are used the methods section must clearly indicate that adequate measures were taken to minimize pain or discomfort. Experiments should be carried out in accordance with the European Communities Council Directive of 24 November 1986 (86/609/EEC) or with the Guidelines laid down by the NIH in the US regarding the care and use of animals for experimental procedures. All studies using human or animal subjects should include an explicit statement in the Methods section identifying the review and approval committee for each study.
Editors reserve the right to reject papers if there is doubt whether appropriate procedures have been used.
Proofs and Offprints
Proofs will be sent via e-mail as an Acrobat PDF (portable document format) file. The e-mail server must be able to accept attachments up to 4 MB in size. Acrobat Reader will be required in order to read this file. This software can be downloaded (free of charge) from the following Web site:
www.adobe.com/prodindex/acrobat/main.html
This will enable the file to be opened, read on screen, and printed out in order for any corrections to be added. Further instructions will be sent with the proof. Proofs will be posted if no e-mail address is available; in your absence, please arrange for a colleague to access your e-mail to retrieve the proofs.
Twenty-five offprints of each article will be sent free of charge to the corresponding author after publication. Additional copies may be purchased using the order form provided with the proofs.
Copyright
It is a condition of publication in the Journal that authors assign copyright to the Soci¨¦t¨¦ Française de Pharmacologie, using the form available on the Copyright Assignment Form page. This ensures that requests from third parties to reproduce articles are handled efficiently and consistently and will also allow the article to be as widely disseminated as possible. In assigning copyright, authors may use their own material in other publications provided that the Journal is acknowledged as the original place of publication, and Blackwell Science Ltd is notified in writing and in advance. | 
